Benzyl alcohol - Shionogi Pharma

Drug Profile

Benzyl alcohol - Shionogi Pharma

Alternative Names: Head Lice Asphyxiator; LARx - Shionogi Pharma; Pediculosis therapy - Shionogi Pharma; Ulesfia

Latest Information Update: 11 Feb 2016

Price : $50

At a glance

  • Originator Summers Laboratories
  • Developer Concordia Pharmaceuticals; Shionogi Pharma
  • Class Alcohols; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Pediculosis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 11 Feb 2016 No recent reports on development identified - Preregistration for Pediculosis in Canada (Topical)
  • 30 Dec 2013 Preregistration for Pediculosis in Canada (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top